REGENEREX PHARMA, INC. Operating Lease Cost
REGENEREX PHARMA, INC. reported Operating Lease Cost of $161.85 thousand for the 9-month period ending 2025-12-31, per its 10-KT filed 2026-08-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-31
- REGENEREX PHARMA, INC. operating lease, cost for fiscal 2025 was $220.16K.
| Period end | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|
| 2025-12-31 | $161.85K 10-KT · filed 2026-08-31 | |
| 2025-03-31 | $220.16K 10-KT · filed 2026-08-31 |